Back to top
more

Merit Medical Systems (MMSI)

(Real Time Quote from BATS)

$96.18 USD

96.18
184,482

-1.28 (-1.31%)

Updated Sep 10, 2024 02:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (174 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Boston Scientific (BSX) Rises 26.4%: Will the Rally Continue?

Boston Scientific (BSX) gains from strong improvement in organic sales, indicating a solid rebound in the legacy business.

Stryker's (SYK) Q Guidance Successful in First Surgery

Stryker (SYK) successfully completes first surgical case using its Q Guidance system with Cranial Guidance software. An Early Product Surveillance is underway for the combined technology.

Catalent (CTLT) Expands Its Facility Capabilities in Shiga

Catalent's (CTLT) latest capability expansion is expected to boost its business in the global clinical trials space in its Clinical Supply Services network.

Abbott (ABT) Reports Upbeat Cardiomems Sensor Study Result

Abbott's (ABT) MONITOR-HF is the third randomized, controlled trial that will provide significant health benefits to indicated heart failure patients.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS (STE) on strong segmental growth.

Why Is Merit Medical (MMSI) Down 1% Since Last Earnings Report?

Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Veeva Systems (VEEV) Offerings Adopted by Minaris Regenerative

Veeva Systems' (VEEV) Vault Quality Suite applications are expected to aid the CDMO to modernize its operations and streamline its quality processes globally.

Medtronic (MDT) to Expand Diabetes Care With New Buyout

Medtronic's (MDT) latest acquisition will increase its capacity to assist more individuals with diabetes worldwide within a single, seamless Medtronic support ecosystem.

Here's Why You Should Retain Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) on continued growth across the entire range of insured and self-insured medical, pharmacy, dental and behavioral health products and services.

Medtronic (MDT) Q4 Earnings Beat Estimates, Margins Down

Strong growth in the Cardiovascular, Medical Surgical, and Neuroscience portfolios, and in Diabetes markets drove Medtronic (MDT) Q4 revenues.

Masimo's (MASI) Platform Expansion to Boost Patient Monitoring

Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

Investors continue to be optimistic about DexCom (DXCM), owing to its strong product portfolio.

Thermo Fisher (TMO) Expands Manufacturing Facility in APAC

Thermo Fisher (TMO) latest expansion will enable it to better assist clients in accelerating their research, development and marketing of medications and vaccines in the Asia-Pacific region.

Accuray (ARAY) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about Accuray's (ARAY) solid product portfolio.

Veeva Systems' (VEEV) New Tie-Up to Improve Clinical Trials

Veeva Systems' (VEEV) latest collaboration is expected to advance the patient experience in clinical trials.

ShockWave Medical (SWAV) Hits 52-Week High: Will it Continue?

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Avantor's (AVTR) New Tie-Up to Improve Lab Inventory Management

Avantor's (AVTR) latest partnership is expected to significantly optimize labs' inventory management and the overall workflow.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Driving It?

Intuitive Surgical (ISRG) outperforms the industry and the S&P 500 Index due to its strength in robotics.

Here's Why Investors Should Add Zimmer Biomet (ZBH) Now

Investors are optimistic about Zimmer Biomet (ZBH) on continued procedure recovery, solid execution and increasing traction around innovations.

3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

QIAGEN (QGEN) Expands Enzyme Offering to Aid Laboratory

QIAGEN is a one-stop shop for all research needs, including solutions for sample preparation, automation and bioinformatics with enzyme offering expansion.

National Vision (EYE) Plans to Open New Stores Amid Macro Woes

National Vision (EYE) plans to continue executing core growth initiatives and further investing in competitive advantages.